Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Microbiological Stability Testing of Emulsions

Posted on By

SOP for Microbiological Stability Testing of Emulsions

Microbiological Stability Testing of Emulsions

1) Purpose

The purpose of this SOP is to describe the procedure for conducting microbiological stability testing on emulsion formulations. This ensures that the emulsions remain free from microbial contamination during storage, maintaining product quality and safety over their shelf life.

2) Scope

This SOP applies to all personnel involved in microbiological stability testing, including the QC microbiology team. It covers the evaluation of microbial contamination over time for both sterile and non-sterile emulsions.

3) Responsibilities

  • QC Microbiology Team: Responsible for conducting microbiological tests and documenting the results at defined intervals.
  • QA Team: Responsible for reviewing and approving test results and ensuring compliance with regulatory guidelines.
  • Formulation Scientists: Responsible for preparing sterile and non-sterile emulsion samples for microbiological testing.
See also  SOP for Preparation of Liposomes using Extrusion Method

4) Procedure

4.1 Sample Preparation

  • 4.1.1 Prepare emulsion formulations in sterilized containers (for sterile emulsions) or controlled aseptic conditions (for non-sterile emulsions).
  • 4.1.2 Label the samples with the batch number, preparation date, and storage conditions.
  • 4.1.3 Store samples under appropriate conditions for stability testing (e.g., 25°C/60% RH, 40°C/75% RH).

4.2 Microbiological Testing Parameters

The following microbiological tests should be performed at specified intervals:

  • 4.2.1 Total Aerobic Microbial Count (TAMC): Perform microbial enumeration to determine the number of viable aerobic microorganisms in the emulsion.
  • 4.2.2 Total Yeast and
Mold Count (TYMC): Perform microbial enumeration to determine the number of viable yeast and mold colonies.
  • 4.2.3 Pathogen Detection: Test for the presence of specific pathogens (e.g., Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli) using selective media.
  • 4.3 Testing Schedule

    • 4.3.1 Initial Test: Conduct microbiological tests immediately after sample preparation to establish a baseline for contamination levels.
    • 4.3.2 Interim Tests: Perform microbiological testing at specified intervals (e.g., 1 month, 3 months, 6 months) during storage.
    • 4.3.3 Final Test: Conduct a final microbiological test at the end of the stability study (e.g., 12 months) to confirm the microbiological stability of the emulsion.

    4.4 Data Recording and Analysis

    • 4.4.1 Record all test results in the Microbiological Stability Test Report (see Annexure 1).
    • 4.4.2 Compare the results with regulatory limits to ensure that microbial levels remain within acceptable ranges.
    • 4.4.3 Analyze trends in microbial growth to determine the risk of contamination and the effectiveness of preservatives used in the formulation.

    4.5 Acceptance Criteria

    The emulsion formulation is considered microbiologically stable if the following criteria are met throughout the study:

    • 4.5.1 The total aerobic microbial count (TAMC) remains within acceptable limits as defined by regulatory guidelines.
    • 4.5.2 The total yeast and mold count (TYMC) remains within acceptable limits.
    • 4.5.3 No specific pathogens are detected throughout the study period.

    5) Abbreviations

    • TAMC: Total Aerobic Microbial Count
    • TYMC: Total Yeast and Mold Count
    • QC: Quality Control
    • QA: Quality Assurance

    6) Documents

    • Microbiological Stability Test Report
    • Batch Manufacturing Record (BMR)
    • Microbial Enumeration Test Report
    • Pathogen Detection Report

    7) References

    • USP <61>: Microbiological Examination of Non-Sterile Products
    • ICH Q6A: Specifications for New Drug Substances and Products

    8) SOP Version

    Version 1.0

    Annexure

    Annexure 1: Microbiological Stability Test Report Template

    Time Point Storage Condition TAMC (cfu/mL) TYMC (cfu/mL) Pathogens Operator Initials
    Initial 25°C/60% RH Below Limit Below Limit None Operator Name
    1 Month 40°C/75% RH Below Limit Below Limit None Operator Name
    3 Months 40°C/75% RH Below Limit Below Limit None Operator Name
    Liposome and Emulsion Formulations Tags:Antioxidants in emulsions, API incorporation in emulsions, API incorporation in liposomes, Chemical stability testing liposomes, Cosmetic emulsion formulation, Emulsion droplet size analysis, Emulsion formulation SOP, Emulsion microbiological stability, Emulsion stability testing, Freeze-thaw stability testing, Heat-sensitive liposomes, High-shear mixing emulsions, Liposomal drug delivery SOP, Liposomal vaccines SOP, Liposome formulation SOP, Liposome particle size analysis, Liposome preparation procedure, Liposome size distribution, Liposome stability testing, Nanoemulsion SOP, Parenteral emulsion preparation, pH-responsive emulsions, Physical stability liposomes, Self-emulsifying drug delivery systems (SEDDS), Thin-film hydration liposomes

    Post navigation

    Previous Post: SOP for Preparation of Nanoparticles for Ocular Delivery
    Next Post: SOP for Handling and Disposal of Hazardous Chemicals

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version